Correlation between SARS-CoV-2 and ebola
DOI:
https://doi.org/10.33448/rsd-v10i16.23772Keywords:
Lethality; COVID-19; SARS-CoV-2; Ebolavirus.Abstract
Introduction: The World Health Organization in 2020 declared the SARS-CoV-2 pandemic, which has high transmissibility causing a fatal acute respiratory syndrome. Furthermore, a rare and deadly disease, in addition to the above mentioned, proven by a virus is Ebola in primates (including man), which constitutes the most deadly and disseminated disease in global outbreaks. Objective: to establish a comparison between coronavirus and Ebola with a focus on mortality and lethality. Methodology: an integrative literature review using online databases such as: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Results and Discussions: In 2020, the 10th Ebola outbreak occurred and the 2nd largest since its discovery in 1976, 3,470 cases were reported. Currently, in 2021, according to Epidemiological Week (SE) 43, on October 30, 246,407,251 cases of COVID-19 have been confirmed in the world. Comparing the coronavirus, which has a fatality rate of 6.1% of infected people, with the threat of the Ebola virus, covering 90%, it is considered more aggravating, as it quickly causes the deaths of the sick. Conclusion: Thus, COVID-19 and Ebola are viruses that threaten global public health, due to their high rates of morbidity and mortality. However, it is necessary to follow the protocols and recommendations of the World Health Organization in the control and prevention of diseases.
References
Baseler, L. & Chertow, D.S. & Johnson, K.M. & Feldmann, H. & Morens, D.M. (2017). The Pathogenesis of Ebola Virus Disease. Annual Review of Pathology: Mechanisms of Disease. 24;12:387-418. 10.1146/annurev-pathol-052016-100506.
Brasil. (2019). Ebola: causas, sintomas, diagnóstico, tratamento e prevenção. https://antigo.saude.gov.br/saude-de-a-z/ebola
Brasil. (2020). Secretaria de Atenção Primária à Saúde (SAPS). Protocolo De Manejo Clínico Do Coronavírus (Covid-19) Na Atenção Primária À Saúde- Versão 9. Recuperado de: http://docs.bvsalud.org/biblioref/2020/05/1095920/20200504-protocolomanejo-ver09.pdf
Brasil. (2021). Ministério da Saúde. Secretaria de Políticas de Saúde. Semana Epidemiológica 43 (24/10 a 30/10/2021). https://www.gov.br/saude/pt-br/media/pdf/2021/novembro/10/boletim_epidemiologico_covid_87_10nov21-substituir.pdf
Brown, C.S. & Mepham, S. & ShorteN, R.J. (2017). Ebola Virus Disease: An Update on Epidemiology, Symptoms, Laboratory Findings, Diagnostic Issues, and Infection Preventionand Control Issues for Laboratory Professionals. Clinics in laboratory medicine. un;37(2):269-284. 10.1016/j.cll.2017.01.003.
Calvo, C. & López-hortelano, M. G. & Vicente, J. & Martínez, J.L.V. (2020). Recommendations on the clinical management of the COVID-19 infection by the «new coronavirus» SARS-CoV2. Spanish Paediatric Association working group. Anales de pediatria, 92(4), 241.e1–241.e11. 10.1016/j.anpede.2020.02.002
Centers for disease control and prevention. (2019). National center for emerging and zoonotic infectious diseases. https://www.cdc.gov/vhf/ebola/index.html
Chen, Y. & Liu, Q. & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology Apr; 92(4): 418–423. 10.1002/jmv.25681
International development research center (IDRC). (2019). O Papel dos Fatores Sociais, Culturais e Ambientais na Melhoria da Resiliência e Resposta à Doença do Vírus Ebola. https://www.idrc.ca/en/project/role-social-cultural-and-environmental-factors-improving-ebola-virus-disease-response-and.
Lai, C. C. & Shih, T.P. & ko W. C. & Tang, H.J.& Hsueh, P.R. (2019). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International jornal of antimicrobial agents. 2020;105924(3):55. 10.1016/j.ijantimicag.2020.105924
Lima, C. (2020). Information about the new coronavírus disease (COVID-19). Radiologia Brasileira. 53(2), V-VI. 10.1590/0100-3984.2020.53.2e1
Nicastri, E. & Kobinger, G. & Vairo, F. & Montaldo, C. & Mboera, L.E. G. & Ansunama, R. & Zumla, A. & Ippolito, G. (2019). Ebola Virus Disease: Epidemiology, Clinical Features, Managementand Prevention. Infectious Disease Clinicsof North America 33(4):953-976. 10.1016/j.idc.2019.08.005. PMID: 31668200.
Paiano, M. et al. (2020). Mental health of healthcare professionals in China during the new coronavirus pandemic: an integrative review. Revista Brasileira de Enfermagem. 73(2), e20200338. https://doi.org/10.1590/0034-7167-2020-0338
Peeri, N. C. & Shrestha, N. & Rahman, S. & Zaki, R. & Tan Z. & Bibi S.& Baghbanzadeh, M.& Aghamohammadi, N. & Zhang, W. & Haque, U. (2020). The SARS, MERS and novel coronavirus (COVID-19) epidemics, thenewestand biggest global healththreats: what lessons have we learned? International Journal of Epidemiology 49(3):717-726. 10.1093/ije/dyaa033.
Prado, M. F. et al. (2020). Análise da subnotificação de COVID-19 no Brasil. Revista Brasileira de Terapia Intensiva. 32(2), 224-228. 10.5935/0103-507X.20200030.
Razai, M. S., Doerholt, K., Ladhani, S., & Oakeshott, P. (2020). Coronavirus disease 2019 (COVID-19): a guide for UK GPs. British medical journal (Clinical research ed.), 368, https://doi.org/10.1136/bmj.m800
Who. (2020). Novo surto de Ebola detectado no noroeste da República Democrática do Congo; Equipe de emergência da OMS apoiando a resposta. https://www.who.int/news/item/01-06-2020-new-ebola-outbreak-detected-in-northwest-democratic-republic-of-the-congo-who-surge-team-supporting-the-response.
Who. (2020). Ebola: Kivu / Ituri do Norte, República Democrática do Congo, https://www.who.int/emergencies/situations/Ebola-2019-drc-.
Who. (2021). Doença pelo vírus Ebola. https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease.
Who. (2021). O Diretor Geral da OMS felicita a República Democrática do Congo quando o 12º surto de Ebola é declarado encerrado; estresses precisam manter vigilância para evitar o retorno do vírus. https://www.who.int/news/item/03-05-2021-who-director-general-congratulates-the-democratic-republic-of-the-congo-as-12th-ebola-outbreak-is-declared-over-stresses-need-to-maintain-vigilance-to-prevent-virus-s-return.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nágila Iane Pacheco; Luiza Aragão Paiva Pires Ferreira Mendes; Gabriel de Sousa Carneiro; Mariana Pacheco de Sousa; Jucilene da Silva Sousa ; Ian Carlos Cavalcante Vasconcelos ; Bruna Ellen Ribeiro de Oliveira; Bruna da Silva Azevedo; Isabelle Vasconcelos Rodrigues; Adryana Ryta Ribeiro Sousa Lira; Jorge Davi de Sousa e Silva; Fernando Henrique Lima Sa Machado; Jordianne Thamires Rodrigues Bezerra; Veronildes de Sousa e Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
